End-to-end solution enables health plans to improve Star ratings though better member compliance on diabetic eye exams and other preventive screenings.
End-to-end solution enables health plans to improve Star ratings though better member compliance on diabetic eye exams and other preventive screenings.
In response to the COVID-19 pandemic, Retina Labs has announced its latest in teleophthalmology innovation with the introduction of a telemedicine-based e-consultation platform specially designed [...]
Retina Labs is pleased to announce that it has moved its Canadian offices to the Montreal Technoparc. The Techoparc is Canada’s most prestigious science park and serves as an innovation and [...]
Retina Labs is pleased to announce that it will sponsor exhibit at the upcoming America's Health Insurance Plans (AHIP) Institute and Expo to be held in Nashville, TN June 19th to 21st, 2019. [...]
Retina Labs is excited to be one of a select group of companies mentioned in this report. Appearing in the category of Telemedicine / Telerefraction, Retina Labs has emerged a leader in the area [...]
November is officially Diabetic Eye Disease Awareness Month. Diabetic eye disease represents a group of eye conditions that affects those with diabetes.
Diabetic retinopathy is on the rise in Ontario. It is estimated that there are 1.2 million people with diabetes in Ontario, with 20% of those expected to experience vision loss.
Retina Labs is pleased to announce that it has been selected by the Ontario Telemedicine Network (OTN) as the solution for its provincial Teleophthalmology Program.